Know Your Industry
This drug finally goes off-patent in 2028, although key to its LOE strategy is its subQ filing
Keytruda
J&J entered into a licensing agreement for Darzalex with this company
These were the two best-selling NON-ONCOLOGY drugs in 2024
Ozempic and Dupixent
These two companies merged in 1999 to form a new company with a portfolio that covers A to Z (much to J&J's chagrin)
Astra and Zeneca
Nick Jonas would probably be singing "SOS" if the CGM from this company that he sponsors stopped working
Dexcom
BMS acquired this company for $13B in 2020 (hint: the answer might just give you a heart attack)
MyoKardia